Got the Munchies for an Egg Sandwich? The Effects of Cannabis on Bowel Motility and Beyond | Journal of Nuclear Medicine Technology
The Endocannabinoid System: Implications in Gastrointestinal Physiology and Pathology

Individuelles bakterielles Getümmel - zm-online

Meta title: Cannabis and Gut Health: Effects on Appetite and Metabolism

Meta description: Explore how long-term cannabis use may affect appetite, eating habits, gut bacteria, digestive health, body weight and metabolism, according to emerging research.

SEO keywords: cannabis and gut health, long-term cannabis use, cannabis appetite effects, gut microbiome, cannabis and metabolism, endocannabinoid system, appetite hormones, cannabinoid hyperemesis syndrome.

Introduction: Beyond the Famous “Munchies”

Cannabis is widely associated with increased appetite. The familiar expression “the munchies” describes the strong desire to eat that some people experience after consuming cannabis, particularly products containing tetrahydrocannabinol (THC). For years, this effect has shaped public perceptions of how cannabis influences eating behaviour, body weight and metabolism. However, emerging research suggests that the relationship between cannabis and the digestive system may be more complicated than previously assumed.

A research update published by the University of Colorado Anschutz on October 8, 2026, highlighted investigations into how frequent, long-term cannabis use may be associated with appetite, dietary patterns, gastrointestinal function and appetite-related hormones. Researchers are exploring an intriguing possibility: while cannabis can temporarily stimulate eating, people who use it frequently over extended periods may experience different appetite patterns.

This question matters because appetite is not controlled by a single mechanism. It depends on communication between the brain, digestive tract, hormones, gut microorganisms, sleep patterns, emotions and the body’s energy requirements. A substance that influences one part of this system may produce several effects that vary with dose, frequency, duration and individual biology.

Researchers are also investigating why some studies have found lower average body mass index (BMI) among long-term cannabis users compared with people who do not use cannabis. Such observations do not establish that cannabis causes weight loss or improves metabolic health. Differences in lifestyle, genetics, diet, other substance use and underlying health conditions may contribute to the findings.

Understanding these distinctions is essential. Cannabis may influence appetite in the short term, but that does not automatically mean that chronic use improves digestion, balances gut bacteria, protects against obesity or benefits overall health.

This article examines the latest research, explains the biological mechanisms involved, explores possible effects on the gut microbiome and metabolism, and discusses the health risks and unanswered questions that deserve attention.

Understanding the October 2026 Research

Investigating the ‘Dark Side’ of Gut Microbes in the Ost Lab

The research discussed in the University of Colorado Anschutz Medical Campus news update focuses on work led by J. Megan Ross, PhD, an associate professor in psychiatry who studies substance use. One of the team’s preliminary studies examined cannabis use frequency, appetite, eating behaviour and body measurements in adult twins. The findings were published in Drug and Alcohol Dependence in October 2026.

The study included 90 adults aged 21–55 who used cannabis at least weekly. The researchers assessed reported appetite, meal frequency, dietary quality and other characteristics. In initial analyses, more frequent cannabis use was associated with lower appetite, fewer meals and a less nutritious diet.

However, the interpretation changed when the researchers examined other factors. After adjusting for alcohol and nicotine use, the initial associations were no longer statistically significant. In comparisons between twins, differences in cannabis use did not significantly explain differences in eating behaviour or diet. Family-related genetic and environmental influences may help explain the patterns observed.

This distinction is important because an association between two things does not prove that one causes the other. For example, people who use cannabis more frequently may differ from other people in sleep, stress, daily routines, food access or other health behaviours. These differences can influence appetite independently of cannabis.

The study was preliminary, and its relatively small sample limits the conclusions that can be drawn. It did not establish that long-term cannabis use reduces appetite, changes metabolism or causes weight loss.

The researchers are pursuing larger investigations that will examine actual food intake and appetite-related hormones, including glucagon-like peptide-1 (GLP-1). Their broader work also examines gastrointestinal symptoms associated with chronic cannabis use. These studies may help clarify why the immediate effects of cannabis can differ from patterns observed among frequent users.

How Cannabis Interacts With the Digestive System

Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome | Nature Reviews Gastroenterology & Hepatology

The digestive system does more than break down food. It absorbs nutrients, regulates fluid balance, communicates with the immune system and sends signals to the brain about hunger and fullness. Cannabis can interact with some of these processes through the body’s endocannabinoid system.

The endocannabinoid system is a network of receptors, naturally produced signalling molecules and enzymes that help regulate several physiological functions. These include appetite, mood, pain perception, memory, energy balance and aspects of gastrointestinal activity.

Two commonly discussed receptors are cannabinoid receptor type 1 (CB1) and cannabinoid receptor type 2 (CB2). CB1 receptors are prominent in the brain and nervous system, where they participate in appetite and reward pathways. They are also present in parts of the digestive tract. CB2 receptors are particularly associated with immune functions and are also found in gastrointestinal tissues.

Cannabis contains many biologically active compounds called cannabinoids. THC is the principal intoxicating compound and can activate CB1 receptors. Cannabidiol (CBD) has different pharmacological effects and does not produce the same intoxicating effects as THC. These compounds should not be treated as interchangeable, because their effects can vary by dose, formulation and route of administration.

When THC activates relevant brain pathways, food can become more rewarding and eating may feel more appealing. Some people notice stronger food cravings, enhanced enjoyment of flavours or a greater desire to snack even when they have recently eaten. Experimental research supports the idea that cannabis can increase short-term energy intake by changing motivation to eat.

However, appetite is only one component of digestion. The digestive tract also coordinates movement, secretion, absorption and signals associated with nausea or fullness. Cannabis may influence some of these processes, but the exact effects of frequent use on normal gastrointestinal function remain incompletely understood.

It is therefore misleading to assume that cannabis automatically improves digestion because it makes food more appealing. Increased interest in food does not necessarily mean that the body absorbs nutrients more effectively, that bowel function improves or that the gut microbiome becomes healthier.

Why Cannabis May Increase Appetite in the Short Term

Neurobiology of food intake in health and disease | Nature Reviews Neuroscience

The short-term appetite-stimulating effect of cannabis has received considerable scientific attention. THC can influence brain networks involved in hunger, reward, smell, taste and motivation. These effects may make food more attractive and encourage a person to begin eating sooner or consume more than they otherwise would.

The hypothalamus, a brain region involved in regulating hunger and energy balance, communicates with other regions that process reward and pleasure. Cannabis can affect this broader network, potentially increasing the appeal of food even when the body does not have an urgent need for additional energy.

A study published in Proceedings of the National Academy of Sciences in December 2025 investigated cannabis-related feeding behaviour in humans and rats. In the human experiments, inhaled cannabis increased energy intake during the first 30 minutes when snacks and beverages were available. The animal experiments helped researchers investigate possible mechanisms behind this response. The study suggested that central cannabinoid receptor signalling can increase motivation to eat.

These results help explain why some people experience the familiar “munchies.” They also demonstrate why the immediate effect of cannabis should be considered separately from its association with appetite over months or years.

A person may eat more during a particular period after cannabis consumption without consistently consuming more food across the entire day. Conversely, someone may experience stronger cravings for calorie-dense snacks but skip regular meals at other times. Total daily energy intake depends on the combined effects of meal timing, portion sizes, food choices, physical activity and other behaviours.

The same research also examined appetite-related hormones in rats and found no significant changes in several circulating hormones after inhalation, despite increased feeding. This suggests that the acute appetite response may involve central brain mechanisms rather than simply being explained by changes in blood hormone levels. Because much of this hormonal evidence came from animals, it cannot automatically be applied to every human cannabis user.

Why Frequent Users May Experience Different Appetite Patterns

The possibility that frequent cannabis users experience different appetite patterns is one of the central questions raised by the October 2026 research update.

Repeated exposure to a substance can produce tolerance, meaning that the body responds less strongly to certain effects over time. A 2025 review of cannabis, weight and weight-related behaviours discussed evidence suggesting that long-term THC exposure may reduce sensitivity to some appetite-stimulating effects. The exact frequency, dose and duration needed for this to occur are not firmly established.

Tolerance could help explain why an effect that is obvious to a new or occasional user may become less noticeable in someone who uses cannabis frequently. Nevertheless, tolerance is not a complete explanation for the lower appetite reported in some research samples.

The 2026 twin study found that more frequent use was initially associated with lower appetite, but its results did not demonstrate a causal relationship. The researchers could not conclude that cannabis itself caused people to feel less hungry. Shared genetic and environmental factors, other substance use and unmeasured characteristics may have influenced the results.

Other factors could also contribute to changing eating patterns. Some frequent users may have irregular schedules, altered sleep, nausea, anxiety or changes in their daily routines. Others may eat more at certain times but less at others. The experience can vary substantially between individuals.

It is also important to distinguish appetite from food intake. Appetite is the desire to eat, whereas food intake is the amount and type of food actually consumed. Someone can report feeling hungry without eating much, or eat more than expected without experiencing strong hunger.

Researchers therefore need to measure these outcomes separately. Objective records of food consumption, repeated appetite assessments, body composition measurements and carefully timed biological samples can provide a clearer picture than a single questionnaire.

The central lesson is that frequent cannabis use should not be assumed to suppress appetite, just as occasional cannabis use should not be assumed to cause persistent overeating. Both responses remain subjects of scientific investigation.

Cannabis and the Gut Microbiome: What Do We Know?

What is the gut microbiome—and how can it affect your health? | National Geographic

The gut microbiome refers to the community of microorganisms living in the digestive tract, including bacteria, fungi, viruses and other microscopic organisms. These communities interact with the food we eat and contribute to digestion, immune function and the production of certain substances that influence the body’s physiology.

A balanced, diverse diet containing adequate fibre supports many beneficial microbial activities. Some gut bacteria ferment dietary fibre to produce short-chain fatty acids, including acetate, propionate and butyrate. These compounds can support the intestinal lining and participate in metabolic and immune signalling.

Because the endocannabinoid system interacts with several physiological pathways, researchers are interested in whether cannabinoids can also influence the gut microbiome. Potential mechanisms include changes in intestinal movement, immune signalling, inflammation and interactions between the gut and brain.

However, the possibility that cannabis affects gut bacteria is not proof that cannabis improves or damages the microbiome in every user.

A 2025 scoping review examined 75 clinical studies involving the gut and oral microbiomes in people using various psychoactive substances, including cannabis. The review identified microbial differences across several substance-use groups, but findings varied considerably by substance and study. Differences in study methods, participant characteristics and definitions of substance use made it difficult to draw consistent conclusions.

This is an important limitation. Research involving several different substances cannot establish a cannabis-specific effect, and microbial differences do not automatically indicate disease. The significance of a microbiome finding depends on which organisms are affected, what they do, the person’s symptoms and other health characteristics.

Diet is another major factor. If frequent cannabis users eat fewer meals or consume less fibre, the microbiome may respond to these dietary patterns. That would not necessarily mean cannabis directly changed the bacteria. The relationship could be indirect, or it could reflect shared lifestyle factors.

Researchers must also account for smoking, alcohol, medications, physical activity and underlying medical conditions. Without adequate control for these influences, it is difficult to separate the effects of cannabis from those of a person’s broader environment.

Future studies should collect stool samples, assess dietary intake and follow participants over time. Comparing measurements before, during and after changes in cannabis use may help determine whether microbiome differences are temporary, persistent or unrelated to cannabis exposure.

At present, there is insufficient evidence to recommend cannabis as a way to improve gut bacteria, restore microbial balance or treat digestive disorders.

Can Long-Term Cannabis Use Change Metabolism?

Frans Hochstenbach

Metabolism describes the chemical processes through which the body converts food into energy, builds and repairs tissues, stores nutrients and maintains essential functions. It involves multiple organs and regulatory systems, including the liver, pancreas, muscles, digestive tract and brain.

When discussing cannabis and metabolism, researchers often examine body weight, blood glucose regulation, insulin sensitivity, appetite, physical activity and energy expenditure. These measures are related, but they are not interchangeable.

For example, a person with a lower BMI does not necessarily have better insulin sensitivity. Similarly, consuming fewer calories does not automatically indicate that the body is processing nutrients more efficiently.

Observational studies have sometimes found that cannabis users have lower average BMI or lower rates of certain metabolic conditions than non-users. Yet these associations are not sufficient to establish a protective effect. Differences in lifestyle, tobacco use, diet, socioeconomic circumstances, medication use and other variables may influence the results.

There are several possible explanations for the observed patterns. Cannabis may alter appetite or eating schedules in some people. Cannabinoids may interact with biological pathways involved in energy regulation. Differences in physical activity, food choices or other behaviours may also contribute.

At present, the relative importance of these possibilities remains uncertain.

Appetite and energy balance

Body weight is influenced by the balance between energy consumed and energy expended over time. If cannabis increases short-term food intake, it may increase energy consumption during that period. Whether this produces sustained weight gain depends on subsequent eating, activity and other physiological responses.

Likewise, if a frequent user experiences reduced appetite and skips meals, total energy intake may decline. But this could also lead to inadequate protein, fibre, vitamins and minerals if the diet is not carefully maintained.

Neither outcome should be assumed to occur in everyone who uses cannabis.

Blood glucose and insulin sensitivity

Glucose regulation is another important research area. Insulin helps move glucose from the bloodstream into cells, while the liver and other organs coordinate the body’s energy supply.

Researchers are investigating whether cannabinoids affect these pathways, but observational associations cannot establish that cannabis prevents diabetes or improves glucose control.

A small randomised pilot study published in 2025 examined four weeks of low-dose CBD use in 16 adults with overweight or obesity who did not have diabetes. It found no significant improvement in glucose tolerance or measurable gut microbiome characteristics compared with placebo. The small sample and short duration mean that the findings cannot settle the broader question of cannabinoid effects on metabolism.

The practical implication is straightforward: cannabis and CBD should not be treated as proven methods of controlling blood sugar, improving insulin sensitivity or preventing metabolic disease.

Energy expenditure and body composition

Metabolic health also depends on how the body uses energy at rest and during activity. Body composition, muscle mass, sleep and exercise habits can influence these processes.

Some cannabis users may become less physically active, while others maintain regular exercise routines. The effects of cannabis on activity and weight-related behaviour vary, and the available evidence does not justify assuming that frequent use increases calorie burning.

Claims that cannabis is a reliable weight-loss aid are therefore unsupported. Weight management is better approached through sustainable eating habits, physical activity, adequate sleep and appropriate clinical care.

Appetite Hormones: Could GLP-1 Explain the Difference?

GLP-1 action Mechanism. Enteroendocrine L-Cell GLP-1 secretion. Metabolic health, satiety and gut motility. Obesity treatment.

Appetite is regulated by a network of hormones and nervous-system signals. Several of these originate in the digestive tract or communicate information about energy stores and food availability.

Two well-known examples are ghrelin and GLP-1. Ghrelin is commonly associated with hunger signalling, while GLP-1 is released in response to food and participates in glucose regulation and signals related to fullness.

Other relevant signals include peptide YY (PYY), insulin and leptin. These hormones work together with the nervous system rather than operating as independent switches.

The October 2026 research update highlighted GLP-1 as one of the hormones that investigators hope to examine in larger studies of cannabis use and appetite. The aim is to understand whether differences in cannabis exposure are associated with measurable changes in food intake and appetite-related biology.

This is an important research direction, but it is not evidence that cannabis acts like a GLP-1 medication.

Prescription medicines that target the GLP-1 pathway have specific pharmacological actions, clinical indications and safety considerations. Cannabis products vary widely in cannabinoid composition, potency and delivery method. They cannot be assumed to produce equivalent effects.

Researchers will need to determine whether any hormonal changes occur consistently, whether they differ between THC and CBD, and whether they actually explain changes in appetite or body weight.

Timing also matters. Hormone concentrations change in response to meals, fasting, sleep and other factors. A single blood sample may miss important fluctuations. Well-designed studies should standardise meal timing, record cannabis exposure and measure hormones at multiple time points.

The latest evidence does not establish that long-term cannabis use consistently raises or lowers GLP-1 in humans. It remains a question for future research.

Digestive Risks: Nausea, Vomiting and Abdominal Pain

Understanding GI Testing: What Your Gut Microbiome Reveals — Nature Doctors

Although appetite stimulation receives much public attention, persistent cannabis use can also be associated with serious gastrointestinal problems. One of the most important is cannabinoid hyperemesis syndrome (CHS).

CHS is characterised by recurrent episodes of severe nausea and vomiting in some people with prolonged, frequent cannabis use. Abdominal pain may also occur. Some people report that hot showers temporarily ease their symptoms, although this is not a reliable diagnostic test.

CHS can be difficult to recognise because cannabis may initially be used to relieve nausea, and its short-term effects can differ from its effects with prolonged exposure. A person might continue using cannabis because they expect it to help, even when it is contributing to recurring symptoms.

The CU Anschutz research update describes ongoing work investigating CHS, including an earlier phase in which people may experience recurring nausea or abdominal discomfort before severe vomiting develops. Researchers are interested in better understanding the timing and mechanisms of these symptoms.

The condition is clinically significant because repeated vomiting can cause dehydration, electrolyte disturbances and kidney complications. Severe symptoms may require emergency treatment.

Anyone experiencing persistent vomiting, difficulty keeping fluids down, fainting, severe abdominal pain or signs of dehydration should seek prompt medical care. Recurrent nausea or abdominal pain in a frequent cannabis user also warrants medical assessment rather than being dismissed as an ordinary side effect.

For people diagnosed with CHS, sustained cessation of cannabis is the central treatment approach. Symptoms may take time to resolve, and medical support can help manage dehydration, vomiting and difficulties stopping use.

Not every digestive complaint in a cannabis user is CHS. Other conditions, including infections, medication effects and gastrointestinal diseases, can cause similar symptoms. A healthcare professional can assess the history and determine whether further investigation is needed.

Diet Quality: Does Cannabis Change What People Eat?

Foods products improving digestive health

The effect of cannabis on eating behaviour involves more than the number of calories consumed. Meal timing, portion sizes, food variety and nutritional quality are also important.

The preliminary twin study reported that families with higher levels of cannabis use showed patterns of fewer meals, lower reported appetite and less nutritious diets. However, these associations were not established as causal, and the within-twin comparisons did not show significant independent effects.

This means the study cannot support a blanket claim that cannabis causes unhealthy eating. It also cannot rule out smaller effects that a study of this size might have been unable to detect.

There are several ways eating patterns could become irregular. Someone may snack more after cannabis use, skip breakfast the following morning or eat at inconsistent times. Another person may experience little appetite and consume fewer meals overall. These are possible patterns, not universal outcomes.

Regardless of cannabis use, a balanced diet should provide sufficient energy, protein, fibre, vitamins and minerals. Affordable sources include lentils, beans, chickpeas, vegetables, seasonal fruit, whole grains, nuts and seeds. For people who consume dairy or other animal foods, these may also contribute useful nutrients.

Hydration is particularly important for anyone experiencing nausea or vomiting. However, drinking water cannot compensate for ongoing severe fluid loss or replace medical treatment when dehydration is significant.

People who notice changes in appetite can benefit from keeping a simple record of meal timing, food intake, nausea, sleep and symptoms. Such a record may help a clinician identify patterns without assuming that cannabis is the only cause.

If appetite loss is persistent or accompanied by unintended weight loss, weakness, ongoing abdominal pain or changes in bowel habits, medical evaluation is advisable.

Who May Be More Vulnerable to Cannabis-Related Digestive Effects?

Not everyone responds to cannabis in the same way. Individual differences in age, genetics, health status, product potency, frequency of use and other medications can influence both immediate effects and longer-term outcomes.

People with existing gastrointestinal conditions may require particular care. Someone with chronic nausea, inflammatory bowel disease, a history of recurrent vomiting or unexplained weight loss should not assume that cannabis will improve the underlying condition.

Although some cannabinoid-based treatments have specific medical uses, evidence for one condition cannot automatically be applied to another. A product that helps one symptom may have different effects on appetite, digestion or other aspects of health.

Other groups may also need additional caution. Adolescents and young adults face particular concerns related to brain development, while pregnant people should discuss cannabis exposure with a healthcare professional and avoid assuming that cannabis is a safe way to manage nausea or appetite changes.

Frequent use can also lead to cannabis use disorder in some people. Warning signs include difficulty cutting down, strong cravings, increasing tolerance, withdrawal symptoms and continued use despite harmful consequences. People experiencing these difficulties may benefit from professional support.

A healthcare professional can help assess digestive symptoms, review medications, investigate unintended weight changes and discuss appropriate options for reducing or stopping cannabis use.

What Should Future Research Investigate?

The October 2026 research update highlights several important gaps in scientific knowledge. Addressing them will require studies that distinguish short-term effects from long-term outcomes and measure biological changes directly rather than relying only on self-reported behaviour.

NUIP Metabolic Kitchen | College of Health | University of Utah Health

Objective measurement of food intake

Researchers need to measure actual meals, portion sizes, calorie intake and nutrient composition. This would help establish whether reported changes in appetite translate into meaningful differences in daily food consumption.

Shilajit for Energy and Testosterone | HL Benefits

Appetite-related hormones

Repeated measurements of GLP-1, ghrelin, insulin and other relevant hormones could reveal whether cannabis exposure is associated with changes in appetite regulation and glucose metabolism.

Microbiologia e virologia clinica: le domande più comuni - The Wom Healthy

Gut microbiome changes

Studies should examine microbial composition and function alongside dietary intake, gastrointestinal symptoms and medication use. This would help distinguish direct effects from changes driven by lifestyle or diet.

CONVALESCENCE Study Update | COVID-19 Longitudinal Health and Wellbeing National Core Study - UCL – University College London

Longitudinal and twin studies

Following people over time, including participants who change or stop cannabis use, could help clarify which changes are reversible and which reflect pre-existing differences. Twin comparisons can help control for shared genetics and upbringing, although they cannot eliminate every source of bias.

Another priority is to distinguish THC-dominant products from CBD products and other cannabinoid formulations. Researchers must also account for potency, route of administration and frequency of exposure.

Larger, well-controlled studies are necessary before cannabis can be considered a treatment for appetite disorders, metabolic conditions or microbiome-related problems. The most useful research will identify not only whether an effect exists, but also which people experience it, under what circumstances and with what potential risks.

Practical Steps for Protecting Digestive Health

While scientists continue investigating the relationship between cannabis and gastrointestinal function, several general habits can support digestive and metabolic health.

  • Maintain regular meals. Consistent meal timing can help people notice changes in appetite and reduce the likelihood of unintentionally skipping meals.
  • Choose a varied diet. Include vegetables, fruit, legumes, whole grains and appropriate protein sources to support nutritional adequacy and gut microbial activity.
  • Stay hydrated. Drink fluids regularly, especially during hot weather or physical activity. Persistent vomiting requires medical assessment.
  • Monitor symptoms. Record recurring nausea, abdominal pain, appetite loss or unintended weight changes and discuss them with a healthcare professional.
  • Avoid self-medicating digestive problems. Cannabis should not be assumed to treat chronic nausea, poor appetite or metabolic disorders without appropriate clinical advice.
  • Seek help when use becomes difficult to control. Support from a qualified healthcare professional can help address dependence, withdrawal and related health concerns.

These measures do not eliminate cannabis-related risks, but they can help identify nutritional problems and encourage earlier assessment of concerning symptoms.

Conclusion: A Complex Relationship That Science Has Not Yet Resolved

Cannabis and gut health are connected through a complex network involving the brain, digestive tract, endocannabinoid system, appetite signals and potentially the gut microbiome. Scientific evidence shows that THC can stimulate short-term food intake, while some studies of frequent users have reported lower appetite or lower average body weight. These findings are not necessarily contradictory because immediate responses and patterns observed over long periods represent different questions.

The October 8, 2026, research update from the University of Colorado Anschutz highlights this uncertainty. Its preliminary twin study found associations between more frequent cannabis use and certain eating behaviours, but the findings did not establish that cannabis caused those patterns. Larger studies examining food intake, appetite-related hormones and gastrointestinal outcomes are needed.

Research into the gut microbiome is also developing, but current evidence is insufficient to conclude that cannabis reliably improves or harms microbial health in all users. Likewise, observations about BMI do not prove that cannabis improves metabolism or prevents diabetes.

An important concern is cannabinoid hyperemesis syndrome, which can cause recurrent severe nausea and vomiting in people with prolonged, frequent cannabis use. Recognising these symptoms and seeking medical care can prevent serious complications.

Ultimately, cannabis should not be viewed as a proven method for weight management, improving gut bacteria or regulating appetite hormones. The priority for researchers is to establish how different forms of cannabis affect different people over time. Until stronger evidence becomes available, informed medical guidance, balanced nutrition and attention to persistent digestive symptoms remain the most responsible approaches to protecting gut and metabolic health.

Author